Digital image analysis of endoscopic ultrasonography is helpful in diagnosing gastric mesenchymal tumors
- Gwang Ha Kim†1Email author,
- Kwang Baek Kim†2Email author,
- Seung Hyun Lee1,
- Hye Kyung Jeon1,
- Do Youn Park3,
- Tae Yong Jeon4,
- Dae Hwan Kim4 and
- Geun Am Song1
© Kim et al.; licensee BioMed Central Ltd. 2014
Received: 20 February 2013
Accepted: 3 January 2014
Published: 8 January 2014
Endoscopic ultrasonography (EUS) is a valuable imaging tool for evaluating subepithelial lesions in the stomach. However, there are few studies on differentiation between gastrointestinal stromal tumors (GISTs) and benign mesenchymal tumors, such as leiomyoma or schwannoma, with the use of EUS. In addition, there are limitations in the analysis of the characteristic features of such tumors due to poor interobserver agreement as a result of subjective interpretation of EUS images. Therefore, the aim of this study was to evaluate the role of digital image analysis in distinguishing the features of GISTs from those of benign mesenchymal tumors on EUS.
We enrolled 65 patients with histopathologically proven gastric GIST, leiomyoma or schwannoma on surgically resected specimens who underwent EUS examination at our endoscopic unit from January 2007 to September 2010. After standardization of the EUS images, brightness values including the mean (Tmean), indicative of echogenicity, and the standard deviation (TSD), indicative of heterogeneity, in the tumors were analyzed.
The Tmean and TSD were significantly higher in GIST than in leiomyoma and schwannoma (p < 0.001). However, there was no significant difference in the Tmean or TSD between benign and malignant GISTs. The sensitivity and specificity were almost optimized for differentiating GIST from leiomyoma or schwannoma when the critical values of Tmean and TSD were 65 and 75, respectively. The presence of at least 1 of these 2 findings in a given tumor resulted in a sensitivity of 94%, specificity of 80%, positive predictive value of 94%, negative predictive value of 80%, and accuracy of 90.8% for predicting GIST.
Digital image analysis provides objective information on EUS images; thus, it can be useful in diagnosing gastric mesenchymal tumors.
KeywordsStomach Endoscopic ultrasonography Mesenchymal tumor Image analysis
Mesenchymal tumor of the stomach is usually discovered incidentally during upper endoscopy for an unrelated condition, and is noted as a firm, protruding subepithelial lesion; however, larger tumors occasionally can cause bleeding . Histopathologically, most of these tumors are completely or partially composed of spindle cells and display smooth muscle or nerve sheath differentiation. Most gastric mesenchymal tumors are gastrointestinal stromal tumors (GISTs) derived from the interstitial cells of Cajal [1–3]. GIST has a risk of metastatic relapse, especially in the peritoneum and liver, even after surgery for localized disease [4, 5]. Therefore, all GISTs are considered potentially malignant and may require resection, even small intramural lesions of the stomach [5, 6].
In practice, the differentiation of GISTs from benign gastric mesenchymal tumors, such as leiomyoma or schwannoma, is essential for effective clinical management. Endoscopic ultrasonography (EUS) is a valuable imaging tool for evaluating mesenchymal tumors because it enables the demonstration of a hypoechoic mass that is contiguous with the fourth hypoechoic layer of the normal gut wall [7–9]. Despite this fact, there are few studies on differentiation between GISTs and benign mesenchymal tumors with the use of EUS [9, 10]. In addition, there are limitations in the analysis of the characteristic features of such tumors due to poor interobserver agreement as a result of subjective interpretation of EUS images [11, 12].
Digital images consist of pixels (picture elements), which are the basic elements that compose a 2-dimensional picture. In digital image analysis, the distribution and spatial variation of pixels is computed using texture analysis in order to extract useful data. Recently, the usefulness of digital image analysis in distinguishing benign from malignant subepithelial lesions on EUS has been reported . Therefore, the aim of this study was to evaluate the role of digital image analysis in distinguishing the features of GISTs from those of benign mesenchymal tumors on EUS.
The medical records of all patients with histopathologically proven gastric GIST, leiomyoma, or schwannoma on surgically resected specimens who underwent EUS examination at our endoscopic unit from January 2007 to September 2010 were retrospectively reviewed. We enrolled 65 patients (27 men and 38 women) with a mean age of 55 years (range, 28–81 years), of which 50 had GIST, 6 leiomyoma, and 9 schwannoma. This study was reviewed and approved by the Institutional Review Board at Pusan National University Hospital.
The tumors were histopathologically proved to be gastric mesenchymal tumors and were classified immunohistochemically as leiomyoma, schwannoma, or GIST . Leiomyoma was defined as a desmin-positive and c-kit (CD117)-negative tumor, schwannoma as an S-100-positive and c-kit-negative tumor, and GIST as a c-kit-positive tumor. GISTs were divided into 4 groups in accordance with the consensus meeting report at the National Institutes of Health .
EUS was performed using a radial-scanning ultrasonic endoscope (GF-UM2000; Olympus, Tokyo, Japan) at 7.5 MHz, and all examinations were performed under intravenous conscious sedation (midazolam with or without meperidine). The tumor was scanned after filling the stomach with 400–600 mL of deaerated water. At least 10 still EUS images were obtained for each lesion, and these images were saved digitally in Windows bitmap format.
EUS images were reviewed by a single experienced endosonographer (G.H.K.) who was kept blinded to the final diagnosis. Only 1 still EUS image of the highest quality was selected for each lesion for further digital image analysis, which was performed on a standard desktop computer.
Digital image analysis
where CenterGray and RimGray denote the brightness values of the anechoic center and outer hyperechoic rim of the scope, respectively, while StandardGray denotes a brightness value to differentiate the anechoic center from the outer hyperechoic rim.
All data are expressed as mean ± SD. The difference in Tmean and TSD among the 3 groups (GIST, leiomyoma and schwannoma) was assessed using a one-way analysis of variance (ANOVA) test. A receiver operating characteristic (ROC) curve was applied to find the best sensitivity and specificity cut-off values of Tmean and TSD for differentiating GIST from leiomyoma or schwannoma. Calculation of the sensitivity, specificity, positive and negative predictive values, and accuracy for differentiating GIST from leiomyoma or schwannoma was also performed. A p-value <0.05 was considered statistically significant. Statistical calculations were performed using SPSS version 12.0 for Windows software (SPSS Inc., Chicago, IL, USA).
Mean (T mean ) and standard deviation (T SD ) of the brightness values after digital image analysis of gastric mesenchymal tumors according to the histopathologic diagnosis
GIST (n = 50)
Leiomyoma (n = 6)
Schwannoma (n = 9)
Tmean (mean ± SD)
82.8 ± 22.5
39.8 ± 18.9
47.0 ± 12.0
TSD (mean ± SD)
83.5 ± 14.4
54.3 ± 21.7
58.3 ± 17.5
When the GISTs were classified into benign or malignant groups according to histologic risk classification, 31 cases were grouped as benign GISTs (very low risk, 7 cases; low risk, 24 cases) and 14 cases as malignant GISTs (intermediate risk, 10 cases; high risk, 4 cases). There was no difference in the Tmean or TSD between benign and malignant GISTs (88.2 ± 21.7 vs 82.1 ± 23.0, p = 0.395; 86.9 ± 12.2 vs 83.3 ± 13.1, p = 0.373, respectively).
Sensitivity, specificity, positive and negative predictive values, and accuracy of the mean (T mean ) and standard deviation (T SD ) of the brightness values that differentiate gastrointestinal stromal tumor (GIST) from non-GIST mesenchymal tumors in the stomach
Sensitivity, % (95% CI)
Specificity, % (95% CI)
PPV, % (95% CI)
NPV, % (95% CI)
Accuracy, % (95% CI)
Tmean ≥ 65
TSD ≥ 75
Of the above 2 features
In our previous study, we evaluated the features that could differentiate GIST from leiomyoma on EUS; heterogeneity, hyperechogenic spots, a marginal halo, and higher echogenicity in comparison with the surrounding muscle layer were helpful for predicting GIST . However, judgment of these findings on EUS images is subjective; this can result in poor interobserver agreement [11, 12]. To overcome this limitation, we attempted to derive more objective findings from EUS images.
A EUS image is composed of pixels, and its echo density is expressed in brightness values from 0 (black) to 255 (white). Analysis of the brightness is, in principle, a method to evaluate the level of echogenicity (expressed as Tmean) and the degree of homogeneity (expressed as TSD). In addition, EUS images can display different characteristics in accordance with various contrasts used during an examination. Therefore, to minimize these differences, we selected the brightness of the anechoic center and outer hyperechoic rim of the EUS scope, which have the least variability, and also standardized the EUS images.
After post-standardized image analysis, both the Tmean and TSD were significantly higher in GIST than in leiomyoma and schwannoma. These results are consistent with those of previous studies that have reported higher echogenicity in comparison with the surrounding muscle layer, and heterogeneity is useful in diagnosing GIST [9, 10, 14]. In other words, we believe it is suitable to express some EUS findings as objective values after digital image analysis.
According to an ROC curve, the values of Tmean and TSD showing the best sensitivity and specificity for GIST were 65 and 75, respectively. If either Tmean ≥ 65 or TSD ≥ 75 was present, the sensitivity and specificity for predicting GIST were 94% and 80%, respectively, consistent with our previous results .
Next, we attempted to differentiate between benign and malignant GISTs on the basis of image analysis after dividing the GISTs into 2 groups (benign or malignant) according to histologic risk classification. However, we found no difference in the Tmean or TSD between benign and malignant GISTs. Previous studies have suggested that large size, exogastric growth, ulceration, cystic changes, hyperechogenic foci, and irregularity of the margin favor a diagnosis of malignant gastrointestinal mesenchymal tumor [7, 8, 15, 16]. In our previous report, only size was an independent predictor on multivariate logistic regression analysis . Therefore, there is still a limitation in predicting the malignant potential of GIST with the use of image analysis.
This study has several limitations. First, this was a retrospective study that compared EUS features between GISTs and benign mesenchymal tumors using digital image analysis. Therefore, there might have been a potential bias when retrospectively reviewing the EUS images. During the EUS examination, we obtained at least 10 endosonographic images to determine the characteristics of gastric mesenchymal tumors; we hoped this would compensate, to some degree, for the limitation of this being a retrospective study. Second, although EUS examinations were performed, patients were selected for surgery according to the clinical opinions and decisions of the medical doctors. Third, the number of patients with leiomyoma or schwannoma included in this study was small, relative to the number of those with GIST. This limitation might be due to the fact that the most common mesenchymal tumor of the stomach is GIST and that other tumors, such as leiomyoma or schwannoma, are rarely encountered in clinics. Lastly, even though we analyzed only the EUS images obtained at 7.5 MHz in order to reduce differences between the images that could be due to different frequencies, the real settings of EUS, such as gain and contrast, were different in each case, which is a limitation inherent to a retrospective study. We did attempt to standardize the EUS images on the basis of the brightness values of the anechoic center and outer hyperechoic rim of the scope. However, this attempt to standardize the EUS images will not completely overcome the limitations of a retrospective study. Therefore, prospective studies will be needed that use the same conditions of settings such as frequency, gain, and contrast.
Gastric mesenchymal tumor is often asymptomatic, and is usually discovered incidentally during upper gastrointestinal endoscopy for an unrelated condition. The main problem in asymptomatic patients is to determine whether the tumor has a malignant potential. Because GISTs have malignant potential, gastric mesenchymal tumors should not be ignored, even if they are small, if the EUS features are suggestive of GIST. Therefore, if the digital image analysis suggests a high possibility of a GIST, it would be better to attempts to obtain tissue (such as by EUS-guided fine-needle aspiration or biopsy) or to resect the tumor (such as by endoscopic or surgical resection). Further large prospective studies are required to validate our results of EUS image analysis of gastric mesenchymal tumors.
In conclusion, digital image analysis provides objective information on EUS images; thus, it can be useful in diagnosing gastric mesenchymal tumors. The results of EUS image analysis, such as Tmean ≥ 65 or TSD ≥ 75, may help to differentiate GIST from leiomyoma or schwannoma.
Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920050).
- Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF: Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol. 2000, 7: 705-712. 10.1007/s10434-000-0705-6.View ArticlePubMedGoogle Scholar
- Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M: CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998, 11: 728-734.PubMedGoogle Scholar
- Miettinen M, Sobin LH, Sarlomo-Rikala M: Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000, 13: 1134-1142. 10.1038/modpathol.3880210.View ArticlePubMedGoogle Scholar
- Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD: Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 2005, 16: 566-578. 10.1093/annonc/mdi127.View ArticlePubMedGoogle Scholar
- Miettinen M, Sobin LH, Lasota J: Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005, 29: 52-68. 10.1097/01.pas.0000146010.92933.de.View ArticlePubMedGoogle Scholar
- Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33: 459-465. 10.1053/hupa.2002.123545.View ArticlePubMedGoogle Scholar
- Chak A, Canto MI, Rosch T, Dittler HJ, Hawes RH, Tio TL, Lightdale CJ, Boyce HW, Scheiman J, Carpenter SL, Van Dam J, Kochman ML, Sivak MV: Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997, 45: 468-473. 10.1016/S0016-5107(97)70175-5.View ArticlePubMedGoogle Scholar
- Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP: Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut. 2000, 46: 88-92. 10.1136/gut.46.1.88.View ArticlePubMedPubMed CentralGoogle Scholar
- Kim GH, Park do Y, Kim S, Kim DH, Choi CW, Heo J, Song GA: Is it possible to differentiate gastric GISTs from gastric leiomyomas by EUS?. World J Gastroenterol. 2009, 15: 3376-3381. 10.3748/wjg.15.3376.View ArticlePubMedPubMed CentralGoogle Scholar
- Okai T, Minamoto T, Ohtsubo K, Minato H, Kurumaya H, Oda Y, Mai M, Sawabu N: Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor. Abdom Imaging. 2003, 28: 301-307. 10.1007/s00261-002-0055-x.View ArticlePubMedGoogle Scholar
- Catalano MF, Sivak MV, Bedford RA, Falk GW, van Stolk R, Presa F, Van Dam J: Observer variation and reproducibility of endoscopic ultrasonography. Gastrointest Endosc. 1995, 41: 115-120. 10.1016/S0016-5107(05)80592-9.View ArticlePubMedGoogle Scholar
- Gress F, Schmitt C, Savides T, Faigel DO, Catalano M, Wassef W, Roubein L, Nickl N, Ciaccia D, Bhutani M, Hoffman B, Affronti J: Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses. Gastrointest Endosc. 2001, 53: 71-76. 10.1067/mge.2001.111384.View ArticlePubMedGoogle Scholar
- Nguyen VX, Nguyen CC, Li B, Das A: Digital image analysis is a useful adjunct to endoscopic ultrasonographic diagnosis of subepithelial lesions of the gastrointestinal tract. J Ultrasound Med. 2010, 29: 1345-1351.PubMedGoogle Scholar
- Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, Wilson M, Hoffman BJ, Hawes RH: Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999, 44: 720-726. 10.1136/gut.44.5.720.View ArticlePubMedPubMed CentralGoogle Scholar
- Rosch T: Endoscopic ultrasonography in upper gastrointestinal submucosal tumors: a literature review. Gastrointest Endosc Clin N Am. 1995, 5: 609-614.PubMedGoogle Scholar
- Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T, Hayakawa T: The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc. 2002, 55: 37-43. 10.1067/mge.2002.120323.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/14/7/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.